Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 2.29
(10.1%)
AUD 2.29
(10.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -44.64 Million AUD | -70.0% |
| 2023 | -26.26 Million AUD | -19.24% |
| 2022 | -17 Million AUD | -124.13% |
| 2021 | -10.29 Million AUD | -37.29% |
| 2020 | -7.04 Million AUD | -53.89% |
| 2019 | -3.74 Million AUD | -52.95% |
| 2018 | -1.71 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -9.07 Million AUD | 47.64% |
| 2024 Q3 | -13.25 Million AUD | 41.02% |
| 2024 FY | - AUD | -55.71% |
| 2024 Q2 | -23.56 Million AUD | -147.6% |
| 2024 Q4 | -13.25 Million AUD | 0.0% |
| 2023 Q4 | -18.54 Million AUD | -156.2% |
| 2023 FY | - AUD | -19.24% |
| 2023 Q3 | -7.23 Million AUD | 58.68% |
| 2023 Q2 | -17.51 Million AUD | -197.27% |
| 2023 Q1 | -5.89 Million AUD | 57.04% |
| 2022 Q1 | -3.46 Million AUD | 52.09% |
| 2022 FY | - AUD | -124.13% |
| 2022 Q4 | -13.71 Million AUD | -172.56% |
| 2022 Q3 | -5.03 Million AUD | 68.29% |
| 2022 Q2 | -15.87 Million AUD | -357.65% |
| 2021 FY | - AUD | -37.29% |
| 2021 Q1 | -2.46 Million AUD | 53.32% |
| 2021 Q4 | -7.23 Million AUD | -169.39% |
| 2021 Q2 | -6.25 Million AUD | -154.06% |
| 2021 Q3 | -2.68 Million AUD | 57.03% |
| 2020 Q1 | -1.67 Million AUD | 0.0% |
| 2020 Q2 | -4.55 Million AUD | -171.99% |
| 2020 Q4 | -5.27 Million AUD | -185.91% |
| 2020 Q3 | -1.84 Million AUD | 59.54% |
| 2020 FY | - AUD | -53.89% |
| 2019 FY | - AUD | -52.95% |
| 2018 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | -741.978% |
| Acrux Limited | -7.93 Million AUD | -462.95% |
| Actinogen Medical Limited | -12.92 Million AUD | -245.538% |
| AnteoTech Limited | -11.57 Million AUD | -285.859% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -2252.856% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -405.454% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -2965.058% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -128.124% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -879.2% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -1276.945% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -1400.765% |
| Biome Australia Limited | -1.57 Million AUD | -2728.928% |
| Biotron Limited | -5.04 Million AUD | -785.855% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -220.759% |
| BTC Health Limited | 1.05 Million AUD | 4330.848% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -295.119% |
| CSL Limited | 4.73 Billion AUD | 100.943% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 186.088% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -348.71% |
| Dimerix Limited | -24.95 Million AUD | -78.887% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 530.319% |
| Hexima Limited | -995.54 Thousand AUD | -4384.748% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -1484.306% |
| Immuron Limited | -6.19 Million AUD | -621.011% |
| Immutep Limited | -42.87 Million AUD | -4.134% |
| Imugene Limited | -147.97 Million AUD | 69.828% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -6097.258% |
| Memphasys Limited | -3.3 Million AUD | -1249.799% |
| Nanollose Limited | -1.14 Million AUD | -3789.498% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 122.406% |
| Noxopharm Limited | -5.94 Million AUD | -650.949% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -2385.552% |
| Nyrada Inc. | -4.59 Million AUD | -871.402% |
| Orthocell Limited | -11.68 Million AUD | -282.22% |
| PharmAust Limited | -9.45 Million AUD | -372.375% |
| Patrys Limited | -3.49 Million AUD | -1178.512% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 30.821% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -466.068% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -521.339% |
| PYC Therapeutics Limited | -38.11 Million AUD | -17.131% |
| Race Oncology Limited | -14.2 Million AUD | -214.345% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 1.606% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -109.082% |
| Starpharma Holdings Limited | -12.57 Million AUD | -254.994% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 294.407% |
| Tissue Repair Ltd | -5.77 Million AUD | -673.119% |
| Zelira Therapeutics Limited | -36.44 Million AUD | -22.52% |